Chrysene-1,2-Diol

Chrysene-1,2-Diol

SCHEMBL4543236

Oc1ccc2c(ccc3c4ccccc4ccc23)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN22 Q9Y2R2 1/20 0.78
HPRT1 P00492 3/20 0.64
HSD17B10 Q99714 3/20 0.55
ALDH1A1 P00352 3/20 0.55
CYP2A6 P11509 1/20 0.55
TSHR P16473 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
POLB P06746 1/20 0.54
TRPM4 Q8TD43 1/20 0.52
CYP1A2 P05177 2/20 0.52
USP2 O75604 1/20 0.52
PAK1 Q13153 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
ERN1 O75460 1/20 0.48
PAX8 Q06710 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL888244 1.00 PTPN22 (0.78) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
Chrysene-1,2-Diol SCHEMBL30621738 1.00 PTPN22 (0.78) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
Formaldehyde SCHEMBL11126870 0.94 PTPN22 (0.69) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
Hydrochloric Acid SCHEMBL28347175 0.88 PTPN22 (1.00) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
SCHEMBL29613822 0.88 PTPN22 (1.00) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
Hydrochloric Acid SCHEMBL27843667 0.88 PTPN22 (1.00) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
SCHEMBL28483 0.88 PTPN22 (1.00) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
SCHEMBL4068022 0.86 PTPN22 (0.95) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
Charcoal, Activated SCHEMBL2574660 0.86 PTPN22 (0.95) PTPN22HPRT1HSD17B10ALDH1A1CYP2A6
Naphthalene SCHEMBL4847677 0.86 PTPN22 (0.95) PTPN22HSD17B10ALDH1A1CYP2A6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110713588-B Hardmask composition, hardmask layer and method of forming pattern 三星SDI株式会社 2022-08-09 CN claimed
US-12424616-B2 Electroactive materials for metal-ion batteries NEXEON LIMITED (GB) 2025-09-23 US disclosed
US-20240372071-A1 ELECTROACTIVE MATERIALS FOR METAL-ION BATTERIES NEXEON LTD (GB) 2024-11-07 US disclosed
US-12062776-B2 Electroactive materials for metal-ion batteries NEXEON LIMITED (GB) 2024-08-13 US disclosed
EP-3638622-B1 ELECTROACTIVE MATERIALS FOR METAL-ION BATTERIES NEXEON LTD (GB) 2024-05-22 EP disclosed
US-20230327078-A1 ELECTROACTIVE MATERIALS FOR METAL-ION BATTERIES NEXEON LIMITED (GB) 2023-10-12 US disclosed
US-11710819-B2 Electroactive materials for metal-ion batteries NEXEON LIMITED (GB) 2023-07-25 US disclosed
EP-3638622-A1 ELECTROACTIVE MATERIALS FOR METAL-ION BATTERIES Nexeon Ltd. (GB) 2020-04-22 EP disclosed
US-20200099043-A1 ELECTROACTIVE MATERIALS FOR METAL-ION BATTERIES NEXEON LIMITED (GB) 2020-03-26 US disclosed
WO-2018229515-A1 ELECTROACTIVE MATERIALS FOR METAL-ION BATTERIES NEXEON LIMITED (GB) 2018-12-20 WO disclosed
EP-2674161-A1 FMO3 inhibitors for treating pain Akron Molecules GmbH (AT) 2013-12-18 EP disclosed
US-20130252924-A1 Compounds and Methods for Treating Pain AKRON MOLECULES GMBH (AT) 2013-09-26 US disclosed
EP-2637649-A2 COMPOUNDS AND METHODS FOR TREATING PAIN Akron Molecules GmbH (AT) 2013-09-18 EP disclosed
WO-2012062925-A2 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES GMBH (AT) 2012-05-18 WO disclosed
US-5128429-A Low temperature block polymerization without randomization RAYCHEM LIMITED (GB) 1992-07-07 US disclosed
EP-0154506-B1 PREPARATION OF ORGANIC POLYMERS RAYCHEM LIMITED (GB) 1992-02-05 EP disclosed
US-4999411-A Polythioethers, polythiocarbonates, polythioamides, polythioimides RAYCHEM LIMITED (GB) 1991-03-12 US disclosed
US-4960835-A ENGINEERING THERMOPLASTICS RAYCHEM LIMITED (GB) 1990-10-02 US disclosed
US-4845179-A CONDENSATION POLYMERIZATION RAYCHEM LIMITED (GB) 1989-07-04 US disclosed
EP-0154506-A2 Preparation of organic polymers RAYCHEM LIMITED (GB) 1985-09-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130252924-A1 Compounds and Methods for Treating Pain TRPV1, ACHE, OPRL1 PTPN22 3940/4885HPRT1 1346/4885HSD17B10 1782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.